What is seborrheic dermatitis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 14, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Seborrheic Dermatitis

Seborrheic dermatitis is a common chronic inflammatory skin condition characterized by greasy yellowish scaling and erythema that primarily affects sebum-rich areas of the body, with pathogenesis linked to Malassezia yeast proliferation, sebaceous gland activity, and immune dysregulation. 1

Clinical Presentation

  • Affected areas: Primarily affects sebum-rich regions including:

    • Scalp (dandruff in mild cases)
    • Face (particularly nasolabial folds, eyebrows, glabella)
    • Ears (including ear canal)
    • Chest
    • Upper back
    • Axillary folds
    • Inframammary folds
    • Inguinal folds 1
  • Appearance:

    • Erythematous macules or plaques
    • Greasy yellowish scaling
    • Variable pruritus
    • In darker skin types: may present with hyper- or hypopigmentation with minimal scaling 2

Predisposing Factors

  • More pronounced in patients with:
    • HIV infection
    • Parkinson's disease
    • Down syndrome 1
    • Immunocompromised states
    • Neurological disorders

Pathophysiology

Three key factors contribute to seborrheic dermatitis:

  1. Lipid secretion by sebaceous glands
  2. Malassezia species colonization (particularly M. ovale and M. furfur)
  3. Immunologic dysregulation 2

Differential Diagnosis

Seborrheic dermatitis must be differentiated from:

  • Acute otitis externa (when affecting ears)
  • Atopic dermatitis (eczema)
  • Psoriasis
  • Contact dermatitis (irritant or allergic)
  • Discoid lupus erythematosus
  • Tinea infections 1

Treatment Approach

First-Line Treatments

  1. Topical antifungal agents:

    • Ketoconazole 2% cream or shampoo (apply once daily for body lesions; twice daily for seborrheic dermatitis for four weeks) 3
    • Other options: ciclopirox, bifonazole, selenium sulfide 1
  2. Anti-inflammatory agents (for short-term use):

    • Low-potency topical corticosteroids
    • Topical calcineurin inhibitors (tacrolimus, pimecrolimus) 1

Scalp Treatment

  • Antifungal shampoos containing:
    • Ketoconazole
    • Selenium sulfide
    • Zinc pyrithione
    • Coal tar 4

Treatment Duration and Monitoring

  • For facial and body seborrheic dermatitis: Apply ketoconazole cream twice daily for four weeks
  • If no clinical improvement after the treatment period, the diagnosis should be reconsidered 3
  • For scalp involvement: Long-term maintenance with antifungal shampoos 4

Maintenance and Prevention

  • Regular use of antifungal products
  • Gentle cleansing with pH-neutral formulations
  • Avoid irritants and potential allergens
  • Keep affected areas dry
  • Apply hypoallergenic moisturizers once daily 1

Special Considerations

  • Refractory cases: Consider evaluating for associated conditions like HIV or Parkinson's disease
  • Prolonged treatment: Avoid extended use of potent topical corticosteroids, especially on the scalp, as they can potentially worsen hair loss 1
  • Allergic reactions: Be aware that topical medications, particularly neomycin-containing products, can cause allergic contact dermatitis 1

Newer Treatment Options

Roflumilast foam has recently been approved as a topical treatment with potential to become a first-line option for seborrheic dermatitis, offering a well-tolerated alternative to traditional therapies 5.

Treatment Pitfalls to Avoid

  • Using greasy topical products that can inhibit absorption of wound exudate and promote superinfection 6
  • Applying topical products shortly before radiation treatment (for patients undergoing radiotherapy) 6
  • Prolonged use of potent corticosteroids, which can lead to skin atrophy, telangiectasia, and potentially worsen hair loss 1
  • Failure to recognize seborrheic dermatitis variants in different skin types, which may present with less scaling and variable erythema 2

References

Guideline

Seborrheic Dermatitis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Unmet needs for patients with seborrheic dermatitis.

Journal of the American Academy of Dermatology, 2024

Research

Diagnosis and treatment of seborrheic dermatitis.

American family physician, 2015

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.